- Home
- INBX vs SPCE Comparison
INBX vs SPCE Comparison
Compare INBX & SPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBX
- SPCE
- Stock Information
- Founded
- INBX 2010
- SPCE 2017
- Country
- INBX United States
- SPCE United States
- Employees
- INBX N/A
- SPCE N/A
- Industry
- INBX Biotechnology: Pharmaceutical Preparations
- SPCE Transportation Services
- Sector
- INBX Health Care
- SPCE Consumer Discretionary
- Exchange
- INBX Nasdaq
- SPCE Nasdaq
- Market Cap
- INBX 178.5M
- SPCE 187.1M
- IPO Year
- INBX 2020
- SPCE N/A
- Fundamental
- Price
- INBX $11.28
- SPCE $3.11
- Analyst Decision
- INBX Hold
- SPCE Hold
- Analyst Count
- INBX 1
- SPCE 5
- Target Price
- INBX N/A
- SPCE $19.85
- AVG Volume (30 Days)
- INBX 94.2K
- SPCE 1.3M
- Earning Date
- INBX 05-20-2025
- SPCE 05-15-2025
- Dividend Yield
- INBX 7.45%
- SPCE N/A
- EPS Growth
- INBX N/A
- SPCE N/A
- EPS
- INBX 112.62
- SPCE N/A
- Revenue
- INBX $200,000.00
- SPCE $7,036,000.00
- Revenue This Year
- INBX N/A
- SPCE N/A
- Revenue Next Year
- INBX N/A
- SPCE $5,510.36
- P/E Ratio
- INBX $0.10
- SPCE N/A
- Revenue Growth
- INBX N/A
- SPCE 3.47
- 52 Week Low
- INBX $10.80
- SPCE $2.18
- 52 Week High
- INBX $18.95
- SPCE $28.20
- Technical
- Relative Strength Index (RSI)
- INBX 41.19
- SPCE 55.18
- Support Level
- INBX $10.90
- SPCE $2.79
- Resistance Level
- INBX $11.98
- SPCE $3.33
- Average True Range (ATR)
- INBX 0.85
- SPCE 0.17
- MACD
- INBX -0.02
- SPCE 0.06
- Stochastic Oscillator
- INBX 19.75
- SPCE 62.07
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About SPCE Virgin Galactic Holdings Inc.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures advanced air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.